iSTAR Medical strengthens board with two senior appointments

Wavre, Belgium: 28 June 2016 - iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, announced today the appointment of Martin Wax, M.D. and Marc Nolet de Brauwere to the Board of Directors.

Dr Martin Wax is a scientific expert in glaucoma with over 30 years of experience in industry and academia. He is currently the Chief Medical Officer and Executive Vice]President of R&D at PanOptica Inc, and was formerly Vice]President and Head of Discovery Research and Pre]Clinical Sciences at Alcon Laboratories.

Marc Nolet de Brauwere has over 30 years of industry experience and a successful track record in building and leading companies in ophthalmology. He is currently on numerous private and public company boards and serves as CEO of PhysIOL, an innovative med-tech company active in the conception, manufacturing and sales of cutting]edge intraocular lenses (IOLs).

More info on iSTAR Medical's website.


Next > NGDATA opens Singapore office to support rapid growth and global expansion

Previous > Nexstim Plc Key Technology Patent Granted in US